Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
